Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer‐induced bone loss

Bone disease is a frequent event in cancer patients, both due to cancer spread to bone and to cancer therapies. Bone is the organ most frequently affected by metastatic disease when considering the two most frequent cancers in the Western world (breast and prostate cancers). Bone metastases can have...

Ausführliche Beschreibung